Computers/IT
Halfpenny Technologies, PEPID
Read More
Month: February 2010
Predicting Prognosis and Treatment Response in Subset of Pancreatic Cancer Patients
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read MoreClarient Launches New Lung Cancer Test
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, has announced the commercial launch of a new lung cancer test, Clarient Insight Dx Pulmotype.
Read More
Testing/Diagnostics
BD Diagnostics, G-Biosciences, Grenier Bio-One GmbH, HYCOR, ViroStat
Read MoreSequenom Licenses Rights to Develop Age-Related Macular Degeneration Test
Sequenom Inc announced an exclusive worldwide licensing agreement with Optherion Inc. The Sequenom Center for Molecular Medicine, obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration. (AMD)
Read More